Literature DB >> 23069656

Platelets govern pre-metastatic tumor communication to bone.

B A Kerr1, N P McCabe, W Feng, T V Byzova.   

Abstract

Although the survival rate for early detected <span class="Disease">cancers is high, once a cancer metastasizes to bone, it is incurable. Interestingly, patients without visible metastases display abnormal bone formation and resorption, suggesting a link between primary cancers and the bone microenvironment prior to metastasis, and this link likely facilitates preparation of the pre-metastatic niche. We hypothesized that communication with the primary tumor would result in bone remodeling alterations, and that platelets could facilitate this communication. By using three tumor models, we demonstrate that primary tumor growth stimulates bone formation measured by microcomputed tomography. Further, platelet depletion prevented tumor-induced bone formation, highlighting the importance of platelets in the communication between tumors and the bone microenvironment. Finally, we determine that platelets sequester a variety of tumor-derived proteins, TGF-β1 and MMP-1 in particular, which regulate bone formation. Thus, our data reveal that platelets function as mediators of tumor-bone communication prior to metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23069656      PMCID: PMC3687027          DOI: 10.1038/onc.2012.447

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Effect of platelet releasate on bone cell migration and recruitment in vitro.

Authors:  Wanda E Oprea; Jeffrey M Karp; Morris M Hosseini; John E Davies
Journal:  J Craniofac Surg       Date:  2003-05       Impact factor: 1.046

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

4.  Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism.

Authors:  Reinhard Gruber; F Karreth; M B Fischer; G Watzek
Journal:  Bone       Date:  2002-05       Impact factor: 4.398

5.  Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.

Authors:  S F Shariat; M Shalev; A Menesses-Diaz; I Y Kim; M W Kattan; T M Wheeler; K M Slawin
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

6.  Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.

Authors:  G G Reinholz; B Getz; L Pederson; E S Sanders; M Subramaniam; J N Ingle; T C Spelsberg
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

7.  The functional role of blood platelet components in angiogenesis.

Authors:  Joong-Sup Rhee; Martin Black; Uwe Schubert; Silvia Fischer; Eberhard Morgenstern; Hans-Peter Hammes; Klaus T Preissner
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

Review 8.  Modulation of prostate cancer growth in bone microenvironments.

Authors:  Magnus Edlund; Shian-Ying Sung; Leland W K Chung
Journal:  J Cell Biochem       Date:  2004-03-01       Impact factor: 4.429

9.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover.

Authors:  John Street; Min Bao; Leo deGuzman; Stuart Bunting; Franklin V Peale; Napoleone Ferrara; Hope Steinmetz; John Hoeffel; Jeffrey L Cleland; Ann Daugherty; Nicholas van Bruggen; H Paul Redmond; Richard A D Carano; Ellen H Filvaroff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

10.  Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis.

Authors:  Elazar Zelzer; William McLean; Yin-Shan Ng; Naomi Fukai; Anthony M Reginato; Stephanie Lovejoy; Patricia A D'Amore; Bjorn R Olsen
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more
  31 in total

Review 1.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

Review 2.  Platelet function beyond hemostasis and thrombosis.

Authors:  Jerry Ware; Adam Corken; Reshma Khetpal
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

Review 3.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

Review 4.  Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.

Authors:  Leah M Cook; Gemma Shay; Arturo Araujo; Arturo Aruajo; Conor C Lynch
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

5.  Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.

Authors:  Alison J Gareau; Colin Brien; Simon Gebremeskel; Robert S Liwski; Brent Johnston; Michael Bezuhly
Journal:  Clin Exp Metastasis       Date:  2018-01-11       Impact factor: 5.150

6.  Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGFβ-1.

Authors:  Bethany A Kerr; Koran S Harris; Lihong Shi; Jeffrey S Willey; David R Soto-Pantoja; Tatiana V Byzova
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

Review 7.  Contributions of the host microenvironment to cancer-induced bone disease.

Authors:  Sam W Z Olechnowicz; Claire M Edwards
Journal:  Cancer Res       Date:  2014-03-05       Impact factor: 12.701

8.  A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.

Authors:  Ryan P Roop; Michael J Naughton; Catherine Van Poznak; Jochen G Schneider; Philip E Lammers; Timothy J Pluard; Farley Johnson; Charles S Eby; Katherine N Weilbaecher
Journal:  Clin Breast Cancer       Date:  2013-12       Impact factor: 3.225

Review 9.  Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.

Authors:  Michaela R Reagan; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2015-11-26       Impact factor: 20.543

10.  Investigating the Osteoinductive Potential of a Decellularized Xenograft Bone Substitute.

Authors:  Daniel N Bracey; Alexander H Jinnah; Jeffrey S Willey; Thorsten M Seyler; Ian D Hutchinson; Patrick W Whitlock; Thomas L Smith; Kerry A Danelson; Cynthia L Emory; Bethany A Kerr
Journal:  Cells Tissues Organs       Date:  2019-10-25       Impact factor: 2.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.